TNFRSF11B and hydrops fetalis: Supporting these observations, the GISSI-HF trial showed that elevated circulating OPG was a strong, independent predictor of mortality and cardiovascular hospitalization in chronic HF patients, emphasizing its potential utility as a biomarker for risk stratification and a possible therapeutic target [28].